US Stock MarketDetailed Quotes

IRMD IRadimed

Watchlist
  • 52.310
  • +0.330+0.63%
Close Mar 11 16:00 ET
  • 52.310
  • 0.0000.00%
Post 16:05 ET
665.13MMarket Cap34.87P/E (TTM)

IRadimed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
11.71%73.24M
11.10%19.39M
11.04%18.33M
11.15%17.93M
13.72%17.6M
23.00%65.56M
17.42%17.45M
23.10%16.5M
26.80%16.13M
25.70%15.48M
Operating revenue
11.71%73.24M
11.10%19.39M
11.04%18.33M
11.15%17.93M
13.72%17.6M
23.00%65.56M
17.42%17.45M
23.10%16.5M
26.80%16.13M
25.70%15.48M
Cost of revenue
9.66%16.89M
14.58%4.63M
12.73%4.13M
-0.62%3.92M
12.17%4.21M
28.15%15.4M
10.87%4.04M
28.02%3.67M
52.76%3.94M
28.06%3.75M
Gross profit
12.34%56.35M
10.05%14.76M
10.55%14.19M
14.96%14.01M
14.22%13.39M
21.50%50.16M
19.54%13.41M
21.77%12.84M
20.19%12.19M
24.97%11.72M
Operating expense
14.15%34.39M
8.57%8.96M
21.21%8.4M
16.05%8.38M
11.99%8.64M
17.42%30.12M
18.47%8.25M
8.14%6.93M
20.93%7.22M
22.36%7.71M
Selling and administrative expenses
15.73%31.55M
10.36%8.39M
19.81%7.76M
21.08%7.58M
12.97%7.82M
16.63%27.26M
19.51%7.6M
9.47%6.48M
17.91%6.26M
19.62%6.92M
-Selling and marketing expense
28.61%15.62M
35.69%4.52M
32.50%3.8M
17.91%3.48M
27.57%3.83M
-4.24%12.14M
-9.16%3.33M
-5.69%2.86M
1.40%2.95M
-2.27%3M
-General and administrative expense
5.39%15.94M
-9.37%3.87M
9.76%3.97M
23.90%4.1M
1.80%3.99M
41.37%15.12M
58.47%4.27M
25.45%3.62M
37.88%3.31M
44.35%3.92M
Research and development costs
-0.95%2.83M
-12.37%569.99K
41.30%639.47K
-16.72%801.13K
3.44%821K
25.49%2.86M
7.56%650.44K
-7.95%452.56K
45.18%961.95K
52.90%793.72K
Operating profit
9.63%21.96M
12.41%5.8M
-1.97%5.79M
13.38%5.63M
18.49%4.75M
28.21%20.04M
21.30%5.16M
42.91%5.91M
19.12%4.96M
30.32%4.01M
Net non-operating interest income expense
17.65%2.19M
220.38%1.86M
Non-operating interest income
17.65%2.19M
----
----
----
----
220.38%1.86M
----
----
----
----
Other net income (expense)
172.89%117.59K
-22.85%-1.65M
25.04%629.2K
91.49%642.22K
44.61%495.15K
-461.13%-161.32K
-915.98%-1.34M
378.40%503.19K
2,459.82%335.39K
2,395.74%342.41K
Gain on sale of security
71.19%-42.89K
----
----
----
----
-417.75%-148.84K
----
----
----
----
Special income (charges)
68.96%-3.87K
----
----
----
----
---12.47K
----
----
----
----
-Gain on sale of property,plant,equipment
68.96%-3.87K
----
----
----
----
---12.47K
----
----
----
----
Other non- operating income (expenses)
--164.35K
---1.6M
25.04%629.2K
91.49%642.22K
44.61%495.15K
----
----
378.40%503.19K
2,459.82%335.39K
2,395.74%342.41K
Income before tax
11.67%24.28M
11.66%6.34M
0.15%6.42M
18.32%6.27M
20.55%5.24M
34.35%21.74M
20.79%5.68M
51.23%6.41M
26.77%5.3M
42.15%4.35M
Income tax
10.91%5.04M
4.87%1.2M
2.05%1.37M
22.30%1.37M
17.31%1.11M
35.59%4.55M
10.87%1.14M
65.52%1.34M
19.17%1.12M
64.59%943.59K
Net income
11.87%19.23M
13.37%5.15M
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
Net income continuous Operations
11.87%19.23M
13.37%5.15M
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
Minority interest income
Net income attributable to the parent company
11.87%19.23M
13.37%5.15M
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.87%19.23M
13.37%5.15M
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
Basic earnings per share
11.76%1.52
13.89%0.41
0.00%0.4
18.18%0.39
22.22%0.33
33.33%1.36
24.14%0.36
48.15%0.4
26.92%0.33
35.00%0.27
Diluted earnings per share
11.11%1.5
11.11%0.4
0.00%0.4
15.15%0.38
18.52%0.32
32.35%1.35
24.14%0.36
48.15%0.4
26.92%0.33
35.00%0.27
Dividend per share
200.00%0.45
0.00%0.15
0.15
0.15
0
0.15
0.15
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 11.71%73.24M11.10%19.39M11.04%18.33M11.15%17.93M13.72%17.6M23.00%65.56M17.42%17.45M23.10%16.5M26.80%16.13M25.70%15.48M
Operating revenue 11.71%73.24M11.10%19.39M11.04%18.33M11.15%17.93M13.72%17.6M23.00%65.56M17.42%17.45M23.10%16.5M26.80%16.13M25.70%15.48M
Cost of revenue 9.66%16.89M14.58%4.63M12.73%4.13M-0.62%3.92M12.17%4.21M28.15%15.4M10.87%4.04M28.02%3.67M52.76%3.94M28.06%3.75M
Gross profit 12.34%56.35M10.05%14.76M10.55%14.19M14.96%14.01M14.22%13.39M21.50%50.16M19.54%13.41M21.77%12.84M20.19%12.19M24.97%11.72M
Operating expense 14.15%34.39M8.57%8.96M21.21%8.4M16.05%8.38M11.99%8.64M17.42%30.12M18.47%8.25M8.14%6.93M20.93%7.22M22.36%7.71M
Selling and administrative expenses 15.73%31.55M10.36%8.39M19.81%7.76M21.08%7.58M12.97%7.82M16.63%27.26M19.51%7.6M9.47%6.48M17.91%6.26M19.62%6.92M
-Selling and marketing expense 28.61%15.62M35.69%4.52M32.50%3.8M17.91%3.48M27.57%3.83M-4.24%12.14M-9.16%3.33M-5.69%2.86M1.40%2.95M-2.27%3M
-General and administrative expense 5.39%15.94M-9.37%3.87M9.76%3.97M23.90%4.1M1.80%3.99M41.37%15.12M58.47%4.27M25.45%3.62M37.88%3.31M44.35%3.92M
Research and development costs -0.95%2.83M-12.37%569.99K41.30%639.47K-16.72%801.13K3.44%821K25.49%2.86M7.56%650.44K-7.95%452.56K45.18%961.95K52.90%793.72K
Operating profit 9.63%21.96M12.41%5.8M-1.97%5.79M13.38%5.63M18.49%4.75M28.21%20.04M21.30%5.16M42.91%5.91M19.12%4.96M30.32%4.01M
Net non-operating interest income expense 17.65%2.19M220.38%1.86M
Non-operating interest income 17.65%2.19M----------------220.38%1.86M----------------
Other net income (expense) 172.89%117.59K-22.85%-1.65M25.04%629.2K91.49%642.22K44.61%495.15K-461.13%-161.32K-915.98%-1.34M378.40%503.19K2,459.82%335.39K2,395.74%342.41K
Gain on sale of security 71.19%-42.89K-----------------417.75%-148.84K----------------
Special income (charges) 68.96%-3.87K-------------------12.47K----------------
-Gain on sale of property,plant,equipment 68.96%-3.87K-------------------12.47K----------------
Other non- operating income (expenses) --164.35K---1.6M25.04%629.2K91.49%642.22K44.61%495.15K--------378.40%503.19K2,459.82%335.39K2,395.74%342.41K
Income before tax 11.67%24.28M11.66%6.34M0.15%6.42M18.32%6.27M20.55%5.24M34.35%21.74M20.79%5.68M51.23%6.41M26.77%5.3M42.15%4.35M
Income tax 10.91%5.04M4.87%1.2M2.05%1.37M22.30%1.37M17.31%1.11M35.59%4.55M10.87%1.14M65.52%1.34M19.17%1.12M64.59%943.59K
Net income 11.87%19.23M13.37%5.15M-0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M
Net income continuous Operations 11.87%19.23M13.37%5.15M-0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M
Minority interest income
Net income attributable to the parent company 11.87%19.23M13.37%5.15M-0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.87%19.23M13.37%5.15M-0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M
Basic earnings per share 11.76%1.5213.89%0.410.00%0.418.18%0.3922.22%0.3333.33%1.3624.14%0.3648.15%0.426.92%0.3335.00%0.27
Diluted earnings per share 11.11%1.511.11%0.40.00%0.415.15%0.3818.52%0.3232.35%1.3524.14%0.3648.15%0.426.92%0.3335.00%0.27
Dividend per share 200.00%0.450.00%0.150.150.1500.150.15
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Strategy
MSTR
260.590
Coinbase
COIN
191.690
Tesla
TSLA
230.580
4
Vale SA
VALE
9.400
5
Salesforce
CRM
277.050
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!